Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 03, 2019 08:30 ET | Source: LexaGene Holdings Inc

LexaGene Featured on ABC Affiliate WCVB-TV Boston

BEVERLY, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops instrumentation and assays for pathogen...
December 10, 2018 08:30 ET | Source: LexaGene Holdings Inc

LexaGene Completes Development of Canine UTI Syndromic Panel

BEVERLY, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops instrumentation and assays for pathogen...
December 03, 2018 08:30 ET | Source: LexaGene Holdings Inc

LexaGene Attends Industry Engagement Meeting with the Department of Homeland Security

BEVERLY, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection,...
November 28, 2018 09:39 ET | Source: LexaGene Holdings Inc

LexaGene Named One of the 10 Most Promising Food Solution Providers

BEVERLY, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection,...
October 22, 2018 16:00 ET | Source: LexaGene Holdings Inc

LX2 Prototype Model Unveiled at AAVLD

BEVERLY, Mass., Oct. 22, 2018 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection,...
October 09, 2018 08:30 ET | Source: LexaGene Holdings Inc

LexaGene To Unveil LX2™ Beta Prototype Design for the Veterinary Market

BEVERLY, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection,...
September 04, 2018 08:30 ET | Source: LexaGene Holdings Inc

LexaGene to Present at Two Upcoming Investor Conferences

BEVERLY, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection,...
July 26, 2018 08:00 ET | Source: LexaGene Holdings Inc

LexaGene Begins Beta Development of Pathogen Detection System

BEVERLY, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection,...
June 18, 2018 08:00 ET | Source: LexaGene Holdings Inc

LexaGene Names Medical Device Veteran Joseph Caruso to Board of Directors

BEVERLY, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection,...
June 06, 2018 08:00 ET | Source: LexaGene Holdings Inc

LexaGene Announces Collaboration with Texas A&M Veterinary Medical Diagnostics Laboratory

BEVERLY, Mass., June 06, 2018 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection,...